1,596 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 679 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5371,596 (+59)

1.05% more ownership

Funds ownership: 78.07%79.12% (+1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,596
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.63B
2 +$2.24B
3 +$584M
4
Barclays
Barclays
United Kingdom
+$245M
5
Goldman Sachs
Goldman Sachs
New York
+$161M

Top Sellers

1 -$1.34B
2 -$387M
3 -$149M
4
Primecap Management
Primecap Management
California
-$147M
5
O
OrbiMed
New York
-$147M
Name Holding Trade Value Shares
Change
Change in
Stake
1301
$389K
1302
$385K
1303
$385K
1304
$382K
1305
$382K
1306
$382K
1307
$379K
1308
$377K
1309
$374K
1310
$373K
1311
$371K
1312
$371K
1313
$370K
1314
$369K
1315
$369K
1316
$367K
1317
$365K
1318
$365K
1319
$361K
1320
$358K
1321
$358K
1322
$358K
1323
$357K
1324
$356K
1325
$355K